Inventiva (IVA) Receivables - Accured (2020 - 2025)
Inventiva's (IVA) quarterly Receivables - Accured came in at $5.0 million in Q2 2025, up 177.65% year-on-year from $1.8 million in Q2 2024, and up 5.93% quarter-over-quarter from $4.8 million in Q4 2024.
Inventiva (IVA) Receivables - Accured (2020 - 2025) Analysis & Trends
Inventiva's Receivables - Accured history runs 6 years deep, the most recent figure standing at $5.0 million for Q2 2025.
- On a quarterly basis, Receivables - Accured rose 177.65% year-over-year to $5.0 million in Q2 2025; TTM through Jun 2025 was $5.0 million, a 177.65% increase from a year earlier, with the FY2024 full-year figure at $4.8 million, up 322.69% from the prior year.
- Receivables - Accured rose to $5.0 million in Q2 2025 per IVA's latest filing, from $4.8 million in the prior quarter.
- Across five years, Receivables - Accured topped out at $5.0 million in Q2 2025 and bottomed at $66157.5 in Q2 2022.
- The 5-year median for Receivables - Accured is $975956.9 (2023), against an average of $1.8 million.
- Biggest YoY gain for Receivables - Accured was 1147.64% in 2023; the steepest drop was 45.67% in 2023.
- Year by year, Receivables - Accured stood at $110973.7 in 2021, then jumped by 596.87% to $773347.5 in 2022, then jumped by 45.67% to $1.1 million in 2023, then surged by 322.69% to $4.8 million in 2024, then increased by 5.93% to $5.0 million in 2025.
- Per Business Quant, the three latest IVA Receivables - Accured figures stand at $5.0 million (Q2 2025), $4.8 million (Q4 2024), and $1.8 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5.04 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Jun 30, 2023 | 825,404.69 |
| Jun 30, 2023 | 825,404.69 |
| Dec 31, 2022 | 773,347.50 |
| Dec 31, 2022 | 773,347.50 |
| Jun 30, 2022 | 66,157.51 |
| Jun 30, 2022 | 66,157.51 |
| Mar 31, 2021 | 110,973.72 |
| Mar 31, 2021 | 110,973.72 |
| Dec 31, 2020 | 2.38 Mn |
| Dec 31, 2020 | 2.38 Mn |